Nuvation Bio Inc. Revenue 2023–2025
Nuvation Bio Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Nuvation Bio Inc. revenue for the quarter ending March 31, 2026 was 83.2 M, a 2598.70% increase year-over-year.
- Nuvation Bio Inc. revenue for the twelve months ending March 31, 2026 was 104.3 M, a 4722.62% increase year-over-year.
- Nuvation Bio Inc. annual revenue for 2025 was 62.9 M, a 698.96% increase from 2024.
- Nuvation Bio Inc. annual revenue for 2024 was 7.9 M.
- Nuvation Bio Inc. annual revenue for 2023 was 0.
Nuvation Bio Inc. (NUVB) — Frequently Asked Questions
Nuvation Bio Inc. (NUVB) is a publicly traded US company. It has a market capitalization of $2M. In fiscal 2025 it reported revenue of $63M and net income of -$205M. Explore NUVB's stock price, financial statements, earnings history, margins and key ratios below.
What is Nuvation Bio Inc.'s market cap?
Nuvation Bio Inc. (NUVB) has a market capitalization of $2M.
What is the NUVB stock price?
NUVB trades at $4.71 (+2.73% on the day).
How much revenue does Nuvation Bio Inc. make?
Nuvation Bio Inc. reported revenue of $63M in fiscal 2025.
Is NUVB profitable?
In fiscal 2025, Nuvation Bio Inc. reported net income of -$205M.